DEFEROXAMINE AS A CHELATING AGENT

被引：3
|
作者：
MCENERY, JT
LEIKIN, S
机构：
来源：
JOURNAL OF PEDIATRICS | 1968年 / 72卷 / 01期
关键词：
D O I：
10.1016/S0022-3476(68)80422-6
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：147 / +
相关论文
共 50 条
  • [1] DEFEROXAMINE AS A CHELATING AGENT
    WESTLIN, WF
    CLINICAL TOXICOLOGY, 1971, 4 (04): : 597 - &
  • [2] Evaluation of a new method of administration of the iron chelating agent deferoxamine
    BorgnaPignatti, C
    Cohen, A
    JOURNAL OF PEDIATRICS, 1997, 130 (01): : 86 - 88
  • [3] The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity
    Umemura, Masanari
    Kim, Jeong-Hwan
    Aoyama, Haruki
    Hoshino, Yujiro
    Fukumura, Hidenobu
    Nakakaji, Rina
    Sato, Itaru
    Ohtake, Makoto
    Akimoto, Taisuke
    Narikawa, Masatoshi
    Tanaka, Ryo
    Fujita, Takayuki
    Yokoyama, Utako
    Taguri, Masataka
    Okumura, Satoshi
    Sato, Motohiko
    Eguchi, Haruki
    Ishikawa, Yoshihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 134 (04) : 203 - 210
  • [4] INHIBITION OF DELAYED ARTERIAL NARROWING BY THE IRON-CHELATING AGENT DEFEROXAMINE
    HARADA, T
    MAYBERG, MR
    JOURNAL OF NEUROSURGERY, 1992, 77 (05) : 763 - 767
  • [5] PREPARATION OF GA-67-FIBRINOGEN USING DEFEROXAMINE, A BIFUNCTIONAL CHELATING AGENT
    KOSLOWSKY, I
    SCOTT, JR
    SHYSH, A
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (06): : E8 - E8
  • [6] THE FIRST PROSPECTIVE RANDOMIZED TRIAL OF SUBCUTANEOUS DEFEROXAMINE AND THE ORALLY-ACTIVE CHELATING AGENT
    POPE, E
    BERKOVITCH, M
    OLIVIERI, NF
    KOREN, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 208 - 208
  • [7] EFFICACY AND SAFETY OF AN IRON CHELATING AGENT, DEFEROXAMINE, IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND HYPOSIDEREMIC ANEMIA
    GIORDANO, N
    BORGHI, C
    SANCASCIANI, S
    MOROZZI, G
    FIORAVANTI, A
    MAGARO, L
    MARCUCCI, P
    FATTORINI, L
    MARCOLONGO, R
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (06): : 959 - 968
  • [8] DEFEROXAMINE, AN EXCELLENT BIFUNCTIONAL CHELATING AGENT FOR LABELING PROTEINS WITH GALLIUM - 67-GA-HSA
    YOKOYAMA, A
    OMOMO, Y
    HORIUCHI, K
    SAJI, H
    YAMAMOTO, K
    ISHII, Y
    TANAKA, H
    TORIZUKA, K
    JOURNAL OF NUCLEAR MEDICINE, 1981, 22 (06) : P32 - P33
  • [9] A STUDY OF THE EFFECTIVENESS OF THE IRON-CHELATING AGENT DEFEROXAMINE AS VASOSPASM PROPHYLAXIS IN A RABBIT MODEL OF SUBARACHNOID HEMORRHAGE
    VOLLMER, DG
    HONGO, K
    OGAWA, H
    TSUKAHARA, T
    KASSELL, NF
    NEUROSURGERY, 1991, 28 (01) : 27 - 32
  • [10] Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent
    Josep, Rosalina
    Wahidiyat, Pustika Amalia
    Trihono, Partini Pudjiastuti
    Yanuarso, Piprim B.
    PAEDIATRICA INDONESIANA, 2012, 52 (05) : 272 - 279
12345